Latest Information Update: 20 Jan 2017
At a glance
- Originator NeuroSearch
- Mechanism of Action Calcium channel antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Stroke
Most Recent Events
- 19 Jan 2017 Discontinued - Preclinical for Stroke in Denmark
- 28 Oct 1997 Suspended-Preclinical for Stroke in Denmark (Unknown route)
- 11 Aug 1995 New profile